Peter Lynch fit · Growth at a reasonable price (GARP)
Is Caris Life Sciences, Inc. Common Stock (CAI) a Peter Lynch Stock?
Some GARP characteristics, but growth or valuation is stretched.
63/100
CSignaux mixtes
3/6 critères validés
Les critères de Peter Lynch, appliqués à CAI
PEG ≤ 1.0
clé—
EPS CAGR ≥ 15%
clé26.0%
Revenue CAGR ≥ 10%
93.9%
Net margin > 0
-28.9%
Comment CAI se classe selon d'autres stratégies
Données financières en direct
Cap. boursière
$7.05B
PER (TTM)
-
ROIC (TTM)
-
Marge brute
61.3%
Questions fréquentes
What is CAI's Peter Lynch fit score?
CAI scores 63/100 on our Peter Lynch fit engine — grade C. Some GARP characteristics, but growth or valuation is stretched.
Does Peter Lynch actually own CAI?
Our score is computed from financial fundamentals against Peter Lynch's published criteria. We don't claim that Peter Lynch personally owns or recommends CAI.
How often is this score updated?
CAI's Peter Lynch fit score is recomputed daily from the latest TTM financials.
Outil éducatif, pas un conseil en investissement. Les scores sont calculés à partir de données financières publiques selon les critères publiés de chaque stratégie d'investissement. Nous ne prétendons pas que Peter Lynch possède ou recommande CAI personnellement.